Rachel Jimenez, MD
Radiation Oncology · Boston, MANPI 1215166178
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,315 of the $28,436 with a category attached, or 71.4%. AstraZeneca accounts for 87.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $25,188 and has fallen 87.6% since, to $3,123 in 2025. Among radiation oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $1895.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$25K
- Daiichi Sankyo Inc.$2K
- IBA Proton Therapy, Inc.$2K
- GE HealthCare$125
- Incyte Corporation$30
What the payments were for
- Consulting fees$20,31571%
- Speaking & faculty fees$1,2734%
- Travel & lodging$6,14222%
- Food & beverage$7072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $24,915 |
| Daiichi Sankyo Inc. | 1 | $1,820 |
| IBA Proton Therapy, Inc. | 2 | $1,546 |
| GE HealthCare | 1 | $125 |
| Incyte Corporation | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$1,820
How this compares
$28,436 in reported general payments places this provider in the 95th percentile of 200 radiation oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Boston
- Peter OrioBoston$1.8M
- Paul NguyenBoston$721K
- Jason EfstathiouBoston$156K
- Jonathan SchoenfeldBoston$53K
- Martin KingBoston$37K
- Raymond MakBoston$36K
- Shannon MacdonaldBoston$33K
- Nima AghdamBoston$29K
- Theodore HongBoston$24K
- Alice HoBoston$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.